A citation-based method for searching scientific literature


List of co-cited articles
14 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Non-invasive prediction of recurrence in bladder cancer by detecting somatic TERT promoter mutations in urine.
Françoise Descotes, Norelyakin Kara, Myriam Decaussin-Petrucci, Eric Piaton, Florence Geiguer, Claire Rodriguez-Lafrasse, Jean E Terrier, Jonathan Lopez, Alain Ruffion. Br J Cancer 2017
39
60

Telomerase reverse transcriptase promoter mutations in bladder cancer: high frequency across stages, detection in urine, and lack of association with outcome.
Yves Allory, Willemien Beukers, Ana Sagrera, Marta Flández, Miriam Marqués, Mirari Márquez, Kirstin A van der Keur, Lars Dyrskjot, Irene Lurkin, Marcel Vermeij,[...]. Eur Urol 2014
156
60

Novel anticancer therapeutics targeting telomerase.
Maria Ruden, Neelu Puri. Cancer Treat Rev 2013
188
40

Telomerase regulates MYC-driven oncogenesis independent of its reverse transcriptase activity.
Cheryl M Koh, Ekta Khattar, Shi Chi Leow, Chia Yi Liu, Julius Muller, Wei Xia Ang, Yinghui Li, Guido Franzoso, Shang Li, Ernesto Guccione,[...]. J Clin Invest 2015
89
40

Telomerase reverse transcriptase (TERT) promoter mutation analysis of benign, malignant and reactive urothelial lesions reveals a subpopulation of inverted papilloma with immortalizing genetic change.
Liang Cheng, Darrell D Davidson, Mingsheng Wang, Antonio Lopez-Beltran, Rodolfo Montironi, Lisha Wang, Puay-Hoon Tan, Gregory T MacLennan, Sean R Williamson, Shaobo Zhang. Histopathology 2016
26
40

TERT promoter mutations in bladder cancer affect patient survival and disease recurrence through modification by a common polymorphism.
P Sivaramakrishna Rachakonda, Ismail Hosen, Petra J de Verdier, Mahdi Fallah, Barbara Heidenreich, Charlotta Ryk, N Peter Wiklund, Gunnar Steineck, Dirk Schadendorf, Kari Hemminki,[...]. Proc Natl Acad Sci U S A 2013
209
40

Toward Personalised Liquid Biopsies for Urothelial Carcinoma: Characterisation of ddPCR and Urinary cfDNA for the Detection of the TERT 228 G>A/T Mutation.
Ilaria J Russo, Yongwon Ju, Naheema S Gordon, Maurice P Zeegers, K K Cheng, Nicholas D James, Richard T Bryan, Douglas G Ward. Bladder Cancer 2018
22
40

Recurrent TERT promoter mutations in urothelial carcinoma and potential clinical applications.
Boaz Kurtis, Jian Zhuge, Caroline Ojaimi, Fei Ye, Dongming Cai, David Zhang, John T Fallon, Minghao Zhong. Ann Diagn Pathol 2016
22
40

Frequency of TERT promoter mutations in human cancers.
João Vinagre, Ana Almeida, Helena Pópulo, Rui Batista, Joana Lyra, Vasco Pinto, Ricardo Coelho, Ricardo Celestino, Hugo Prazeres, Luis Lima,[...]. Nat Commun 2013
512
40

TERT promoter mutations occur early in urothelial neoplasia and are biomarkers of early disease and disease recurrence in urine.
Isaac Kinde, Enrico Munari, Sheila F Faraj, Ralph H Hruban, Mark Schoenberg, Trinity Bivalacqua, Mohamad Allaf, Simeon Springer, Yuxuan Wang, Luis A Diaz,[...]. Cancer Res 2013
164
40

TERT promoter mutations and TERT mRNA but not FGFR3 mutations are urinary biomarkers in Han Chinese patients with urothelial bladder cancer.
Kun Wang, Tiantian Liu, Cheng Liu, Yan Meng, Xiaotian Yuan, Li Liu, Nan Ge, Jikai Liu, Chang Wang, Hongbo Ren,[...]. Oncologist 2015
21
40

Combined genetic and epigenetic alterations of the TERT promoter affect clinical and biological behavior of bladder cancer.
Ricardo Leão, Donghyun Lee, Arnaldo Figueiredo, Thomas Hermanns, Peter Wild, Martin Komosa, Irene Lau, Mathew Mistry, Nuno Miguel Nunes, Aryeh J Price,[...]. Int J Cancer 2019
21
40

Detection of multiple mutations in urinary exfoliated cells from male bladder cancer patients at diagnosis and during follow-up.
Rossana Critelli, Francesca Fasanelli, Marco Oderda, Silvia Polidoro, Manuela Bianca Assumma, Clara Viberti, Mirko Preto, Paolo Gontero, Giuseppina Cucchiarale, Irene Lurkin,[...]. Oncotarget 2016
29
40

Mutations in TERT promoter and FGFR3 and telomere length in bladder cancer.
Ismail Hosen, P Sivaramakrishna Rachakonda, Barbara Heidenreich, Petra J de Verdier, Charlotta Ryk, Gunnar Steineck, Kari Hemminki, Rajiv Kumar. Int J Cancer 2015
56
40


Genes involved in senescence and immortalization.
A S Lundberg, W C Hahn, P Gupta, R A Weinberg. Curr Opin Cell Biol 2000
225
20

G-quadruplex formation at the 3' end of telomere DNA inhibits its extension by telomerase, polymerase and unwinding by helicase.
Quan Wang, Jia-quan Liu, Zhao Chen, Ke-wei Zheng, Chang-yue Chen, Yu-Hua Hao, Zheng Tan. Nucleic Acids Res 2011
86
20

Antagonistic effects of telomerase on cancer and aging in K5-mTert transgenic mice.
Eva González-Suárez, Christoph Geserick, Juana M Flores, María A Blasco. Oncogene 2005
63
20






Conditional telomerase induction causes proliferation of hair follicle stem cells.
Kavita Y Sarin, Peggie Cheung, Daniel Gilison, Eunice Lee, Ruth I Tennen, Estee Wang, Maja K Artandi, Anthony E Oro, Steven E Artandi. Nature 2005
307
20

Feedback regulation of telomerase reverse transcriptase: new insight into the evolving field of telomerase in cancer.
Xiao-Qin Wu, Cheng Huang, Xu He, Yuan-Yao Tian, De-Xi Zhou, Yong He, Xin-Hua Liu, Jun Li. Cell Signal 2013
37
20


Targeting critical steps of cancer metastasis and recurrence using telomerase template antagonists.
Z Gunnur Dikmen, Taner Ozgurtas, Sergei M Gryaznov, Brittney-Shea Herbert. Biochim Biophys Acta 2009
14
20

Telomere biology: Rationale for diagnostics and therapeutics in cancer.
Philippe Rousseau, Chantal Autexier. RNA Biol 2015
15
20

The telomerase activator TA-65 elongates short telomeres and increases health span of adult/old mice without increasing cancer incidence.
Bruno Bernardes de Jesus, Kerstin Schneeberger, Elsa Vera, Agueda Tejera, Calvin B Harley, Maria A Blasco. Aging Cell 2011
149
20

Expanding the clinical phenotype of autosomal dominant dyskeratosis congenita caused by TERT mutations.
Lina Basel-Vanagaite, Inderjeet Dokal, Hannah Tamary, Abraham Avigdor, Ben Zion Garty, Alexander Volkov, Tom Vulliamy. Haematologica 2008
31
20


Green tea catechin, epigallocatechin-3-gallate (EGCG): mechanisms, perspectives and clinical applications.
Brahma N Singh, Sharmila Shankar, Rakesh K Srivastava. Biochem Pharmacol 2011
688
20


Involvement of 14-3-3 proteins in nuclear localization of telomerase.
H Seimiya, H Sawada, Y Muramatsu, M Shimizu, K Ohko, K Yamane, T Tsuruo. EMBO J 2000
234
20

Massively parallel sequencing of phyllodes tumours of the breast reveals actionable mutations, and TERT promoter hotspot mutations and TERT gene amplification as likely drivers of progression.
Salvatore Piscuoglio, Charlotte Ky Ng, Melissa Murray, Kathleen A Burke, Marcia Edelweiss, Felipe C Geyer, Gabriel S Macedo, Akiko Inagaki, Anastasios D Papanastasiou, Luciano G Martelotto,[...]. J Pathol 2016
64
20


Telomere dynamics in arteries and mononuclear cells of diabetic patients: effect of diabetes and of glycemic control.
Orit Uziel, Joelle Attal Singer, Vladimir Danicek, Gideon Sahar, Evgeny Berkov, Michael Luchansky, Abigail Fraser, Ron Ram, Meir Lahav. Exp Gerontol 2007
91
20

The Telomeric Complex and Metabolic Disease.
Henriette Kirchner, Fozia Shaheen, Hannes Kalscheuer, Sebastian M Schmid, Henrik Oster, Hendrik Lehnert. Genes (Basel) 2017
29
20


The cationic porphyrin TMPyP4 down-regulates c-MYC and human telomerase reverse transcriptase expression and inhibits tumor growth in vivo.
Cory L Grand, Haiyong Han, Rubén M Muñoz, Steve Weitman, Daniel D Von Hoff, Laurence H Hurley, David J Bearss. Mol Cancer Ther 2002
262
20


Telomerase inhibition with a novel G-quadruplex-interactive agent, telomestatin: in vitro and in vivo studies in acute leukemia.
T Tauchi, K Shin-ya, G Sashida, M Sumi, S Okabe, J H Ohyashiki, K Ohyashiki. Oncogene 2006
152
20

Proteasome regulation by ADP-ribosylation.
Park F Cho-Park, Hermann Steller. Cell 2013
92
20

RNaseH1 regulates TERRA-telomeric DNA hybrids and telomere maintenance in ALT tumour cells.
Rajika Arora, Yongwoo Lee, Harry Wischnewski, Catherine M Brun, Tobias Schwarz, Claus M Azzalin. Nat Commun 2014
196
20


Telomerase reactivation following telomere dysfunction yields murine prostate tumors with bone metastases.
Zhihu Ding, Chang-Jiun Wu, Mariela Jaskelioff, Elena Ivanova, Maria Kost-Alimova, Alexei Protopopov, Gerald C Chu, Guocan Wang, Xin Lu, Emma S Labrot,[...]. Cell 2012
152
20


Potential of telomerase activation in extending health span and longevity.
Bruno Bernardes de Jesus, Maria A Blasco. Curr Opin Cell Biol 2012
25
20

Hallmarks of telomeres in ageing research.
J W Shay, W E Wright. J Pathol 2007
133
20

Phenotypes in mTERT⁺/⁻ and mTERT⁻/⁻ mice are due to short telomeres, not telomere-independent functions of telomerase reverse transcriptase.
Margaret A Strong, Sofia L Vidal-Cardenas, Baktiar Karim, Huimin Yu, Nini Guo, Carol W Greider. Mol Cell Biol 2011
83
20


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.